Abstract:Introduction: Acceleration and improvement of penetration across cell-membrane interfaces of active targeted nanotherapeutics into tumor cells would improve tumor-therapy efficacy by overcoming the issue of poor drug penetration. Cell-penetrating peptides, especially synthetic polyarginine, have shown promise in facilitating cargo delivery. However, it is unknown whether polyarginine can work to overcome the membrane interface in an inserted pattern for cyclic peptide ligand-mediated active targeting drug delivery. Here, we conducted a study to test the hypothesis that tandem-insert nona-arginine (tiR(9)) can act as an accelerating component for intracellular internalization, enhance cellular penetration, and promote antitumor efficacy of active targeted cyclic asparagine-glycine-arginine (cNGR)-decorated nanoliposomes. Methods: Polyarginine was coupled with the polyethylene glycol (PEG) chain and the cNGR moiety, yielding a cNGR-tiR(9)-PEG(2,000)-distearoylphosphatidylethanolamine conjugate. Results: The accelerating active targeted liposome (Lip) nanocarrier (cNGR-tiR(9)-Lip-doxorubicin [Dox]) constructed in this study held suitable physiochemical features, such as appropriate particle size of similar to 150 nm and sustained-release profiles. Subsequently, tiR(9) was shown to enhance cellular drug delivery of Dox-loaded active targeted systems (cNGR-Lip-Dox) significantly. Layer-by-layer confocal microscopy indicated that the tandem-insert polyarginine accelerated active targeted system entry into deeper intracellular regions based on observations at marginal and center locations. tiR(9) enhanced the penetration depth of cNGR-Lip-coumarin 6 through subcellular membrane barriers and caused its specific accumulation in mitochondria, endoplasmic reticulum, and Golgi apparatus. It was also obvious that cNGR-tiR(9)-Lip-Dox induced enhanced apoptosis and activated caspase 3/7. Moreover, compared with cNGR-Lip-Dox, cNGR-tiR(9)-Lip-Dox induced a significantly higher anti proliferative effect and markedly suppressed tumor growth in HT1080-bearing nude mice. Conclusion: This active tumor-targeting nanocarrier incorporating a tandem-insert polyarginine (tiR(9)) as an accelerating motif shows promise as an effective drug-delivery system to accelerate translocation of drugs across tumor-cell/subcellular membrane barriers to achieve improved specific tumor therapy.

Multibarrier-Penetrating Drug Delivery Systems for Deep Tumor Therapy Based on Synergistic Penetration Strategy

A Ph‐responsive Nanoparticle Delivery System Containing Dihydralazine and Doxorubicin‐based Prodrug for Enhancing Antitumor Efficacy

A Novel Strategy Through Combining Irgd Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration.

Tumor-penetrating Peptide Mediation: an Effective Strategy for Improving the Transport of Liposomes in Tumor Tissue.

Deepened Cellular/subcellular Interface Penetration and Enhanced Antitumor Efficacy of Cyclic Peptidic Ligand-Decorated Accelerating Active Targeted Nanomedicines

A novel strategy based on a ligand-switchable nanoparticle delivery system for deep tumor penetration

Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells

Tumor-Targeting Micelles Based on Linear Dendritic PEG-PTX8 Conjugate for Triple Negative Breast Cancer Therapy

Magnetically Actuated Active Deep Tumor Penetration of Deformable Large Nanocarriers for Enhanced Cancer Therapy

In situ phagocyte-mediated deep tumor penetration assisted by ApoA-1 mimetic peptide-modified silicasome

Size-switchable and Dual-Targeting Nanomedicine for Cancer Chemoimmunotherapy by Potentiating Deep Tumor Penetration and Antitumor Immunity

Facile fabrication of multi-pocket nanoparticles with stepwise size transition for promoting deep penetration and tumor targeting

FNIII14 Peptide-Enriched Membrane Nanocarrier to Disrupt Stromal Barriers through Reversing CAFs for Augmenting Drug Penetration in Tumors

A NIR light triggered disintegratable nanoplatform for enhanced penetration and chemotherapy in deep tumor tissues

Prodrug-Based Versatile Nanomedicine with Simultaneous Physical and Physiological Tumor Penetration for Enhanced Cancer Chemo-Immunotherapy

Multifunctional Micellar Nanocarriers for Tumor-Targeted Delivery of Hydrophobic Drugs.

A Multi-functional Drug Delivery System Based on Dendritic Peptide for Tumor Nuclear Accurate Targeting Therapy

Enhancing Drug Penetration in Solid Tumors Via Nanomedicine: Evaluation Models, Strategies and Perspectives

Solid Tumor Penetration by Integrin-Mediated Pegylated Poly(trimethylene Carbonate) Nanoparticles Loaded with Paclitaxel.

Targeting peptide-decorated biomimetic lipoproteins improve deep penetration and cancer cells accessibility in solid tumor

A Nanosized Codelivery System Based on Intracellular Stimuli-Triggered Dual-Drug Release for Multilevel Chemotherapy Amplification in Drug-Resistant Breast Cancer